Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Josep M, Guardiola"'
Autor:
Óscar Brochado, Isidoro Martínez, Juan Berenguer, Luz Medrano, Juan González-García, María Ángeles Jiménez-Sousa, Ana Carrero, Víctor Hontañón, Jordi Navarro, Josep M. Guardiola, Amanda Fernández-Rodríguez, Salvador Resino, the GESIDA Study Group
Publikováno v:
Journal of Biomedical Science, Vol 28, Iss 1, Pp 1-14 (2021)
Abstract Objective To evaluate the impact of hepatitis C virus (HCV) elimination via interferon (IFN)-based therapy on gene expression profiles related to the immune system in HIV/HCV-coinfected patients. Methods We conducted a prospective study in 2
Externí odkaz:
https://doaj.org/article/9ba9749c3585451b98a460fd99085b24
Autor:
Lorena Vigón, Sonia Vázquez-Morón, Juan Berenguer, Juan González-García, Ma Ángeles Jiménez-Sousa, Josep M. Guardiola, Manuel Crespo, Ignacio de Los Santos, Miguel A. Von Wichmann, Ana Carrero, María Belén Yélamos, Julián Gómez, Salvador Resino, Isidoro Martínez, The GESIDA 3603b Cohort Study Group
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Abstract The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected pati
Externí odkaz:
https://doaj.org/article/95a0dae2b93d4d7bbc800030ea9bfa0a
Autor:
Teresa Aldámiz-Echevarría, Juan González-García, Miguel A. Von Wichmann, Manel Crespo, José López-Aldeguer, Carmen Quereda, María J. Téllez, María J. Galindo, José Sanz, Ignacio Santos, Josep M. Guardiola, José M. Bellón, Marisa Montes, Juan Berenguer, M.D., Ph.D.
Publikováno v:
Annals of Hepatology, Vol 14, Iss 4, Pp 464-469 (2015)
Background and rationale for the study. We assessed the association of CD4+ T-cell counts and HIV-RNA on sustained viral response (SVR) after therapy with pegylated interferon and ribavirin (PR) in HIV/HCV coinfected patients. We examined two large c
Externí odkaz:
https://doaj.org/article/889d97a941ba4b0885b0c123a1949b85
Autor:
Ana, Carrero, Juan, Berenguer, Víctor, Hontañón, Josep M, Guardiola, Jordi, Navarro, Miguel A, von Wichmann, María J, Téllez, Carmen, Quereda, Ignacio, Santos, José, Sanz, María J, Galindo, José, Hernández-Quero, María A, Jiménez-Sousa, Leire, Pérez-Latorre, José M, Bellón, Salvador, Resino, Herminia, Esteban, Esteban, Martínez, Juan, González-García, H, Esteban
Publikováno v:
CLINICAL INFECTIOUS DISEASES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background Little is known about the effects of eradication of hepatitis C virus (HCV) on bone mineral density (BMD) and biomarkers of bone remodeling in human immunodeficiency virus (HIV)/HCV-coinfected patients. Methods We prospectively assessed st
Autor:
Pilar Garcia-Broncano, Luz Maria Medrano, Juan Berenguer, Juan González-García, Mª Ángeles Jiménez-Sousa, Ana Carrero, Victor Hontañón, Josep M. Guardiola, Manuel Crespo, Carmen Quereda, José Sanz, Ana Belen García-Gómez, Jose Luis Jimenez, Salvador Resino, the GESIDA 3603b Study Group
Publikováno v:
Cells, Vol 7, Iss 11, p 196 (2018)
Background: Advanced cirrhosis is related to alterations in immunity. We aimed to evaluate the levels of peripheral CD4+ T cells (Tregs) and plasma cytokine in patients coinfected with human immunodeficiency virus and hepatitis C virus (HIV/HCV) acco
Externí odkaz:
https://doaj.org/article/23e693ebf2f4496a815c7962a81a881a
Autor:
Luis M Real, Karin Neukam, Rocío Herrero, Josep M Guardiola, Thomas Reiberger, Antonio Rivero-Juarez, Juliana Salazar, Mattias Mandorfer, Dolores Merino, Vicente Soriano, Antonio Rivero, Juan Macías, Juan A Pineda, Antonio Caruz
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e95515 (2014)
ObjectivesThe rs12979860 variant, linked to IL28B gene, predicts sustained viral response (SVR) to pegylated-interferon/ribavirin (pegIFN/RBV) therapy in Hepatitis C Virus genotype 1 or 4 (HCV-1/4)-infected patients. Recently, a functional variant, s
Externí odkaz:
https://doaj.org/article/de6f613c61a94af99f5f7688fb8f44dd
Autor:
José Sanz, Isabel Canorea, Josep M. Guardiola, Ana Carrero, Luz Maria Medrano, Juan Berenguer, María Ángeles Jiménez-Sousa, Carmen Quereda, Juan González-García, Manuel Crespo, Hontañón, Salvador Resino, M. A. Muñoz-Fernández, Pilar Garcia-Broncano
Publikováno v:
AIDS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
OBJECTIVES: Immune dysregulation is a hallmark of HIV and hepatitis C virus (HCV) infections. We aimed to evaluate the relationship between liver stiffness measurement (LSM) and biomarkers of T-cell activation, bacterial translocation, inflammation,
Autor:
José Sanz, Manuel Crespo, Juan González-García, Carmen Quereda, María Ángeles Jiménez-Sousa, Ana Avellón, Salvador Resino, Josep M. Guardiola, Isabel Canorea, Ana Carrero, Víctor Hontañón, Juan Berenguer, Sonia Vázquez-Morón
Publikováno v:
Scientific Reports
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
Scientific Reports, Vol 9, Iss 1, Pp 1-7 (2019)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
Scientific Reports, Vol 9, Iss 1, Pp 1-7 (2019)
Hepatitis E virus (HEV) has emerged as a relevant pathogen for HIV-infected patients. However, there is scarce data on HEV infection in HIV/HCV-coinfected individuals with advanced fibrosis, which seems to increase the risk of HEV infection and worse
Autor:
Adolfo Gallego, María José Faus, Maria Antonia Mangues, Laura Tuneu, Montserrat Masip, Neus Pagès, Josep M. Guardiola, Xavier Torras
Publikováno v:
International Journal of Clinical Pharmacy
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto Cervantes
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto Cervantes
Background Current treatment combinations for chronic hepatitis C virus infection still include pegylated interferon and ribavirin despite the new therapeutic options available. Interferon-based treatments are associated with a high incidence of adve
Autor:
Ana Guelar, JM Llibre, E Deig, Adrian Curran, Enric Pedrol, M Tasias, Josep M. Guardiola, L Tikhomirova, R Ramírez, O Martínez-Madrid
Publikováno v:
HIV Medicine. 16:628-634
Objectives The primary objective was to evaluate the improvement in neuropsychiatric symptoms attributed to an antiretroviral drug after that drug was substituted with nevirapine. The secondary objective was to evaluate the impact on patient adherenc